GlassScriptPhysician profile
Lawrence H Peters
NPI 1417927229
$12,800.06
in general payments reported to CMS, 2019-2025
44 companies · $600 in 2025
The $600 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,396 · 2020: $1,308 · 2021: $2,038 · 2022: $2,085 · 2023: $1,639 · 2024: $3,734 · 2025: $600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,926 · Debt Forgiveness: $1,676 · Travel and Lodging: $1,372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,925.62 |
| Debt Forgiveness | $1,676.06 |
| Travel and Lodging | $1,371.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,811.67 | 2021-2025 | Intellis Adaptivestim, Synchromedii |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,225.16 | 2019-2024 | Relistor |
| Si-Bone, INC. | $1,184.43 | 2020-2024 | |
| Collegium Pharmaceutical, INC. | $976.13 | 2019-2024 | Xtampza, Belbuca |
| Abbvie INC. | $503.86 | 2021-2024 | |
| Nevro Corp. | $459.51 | 2019-2024 | Senza |
| Pfizer INC. | $440.43 | 2019-2024 | |
| Scilex Pharmaceuticals INC. | $408.59 | 2019-2024 | Ztlido |
| Protega Pharmaceutials INC | $325.83 | 2022-2023 | Roxybond |
| Nalu Medical, INC. | $286.11 | 2021 | |
| Biodelivery Sciences International, INC. | $276.34 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $270.70 | 2019-2023 | Ajovy, Austedo |
| Boston Scientific Corporation | $255.20 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $247.48 | 2019-2020 | |
| Redhill Biopharma INC. | $245.74 | 2020-2022 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Peters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.